CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer - ScienceDirect
Molecules | Free Full-Text | Development of CDK4/6 Inhibitors: A Five Years Update
Co-inhibitory signals. (A) CTLA-4 signal may inhibit T cells through... | Download Scientific Diagram
Treating cancer with selective CDK4/6 inhibitors | Nature Reviews Clinical Oncology
Discovery of novel CDK inhibitors via scaffold hopping from CAN508 - ScienceDirect
Senescence as a therapeutically relevant response to CDK4/6 inhibitors | Oncogene
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19 | SpringerLink
Uptake és efflux transzporterekkel kölcsönható vegyületek azonosítása robotizált platformon